Deutsche Bank analyst Pito Chickering upgraded the rating on Boston Scientific (BSX – Research Report) to a Buy today, setting a price target ...
Deutsche Bank upgraded Boston Scientific (BSX) to Buy from Hold with a price target of $108, up from $87. Boston Scientific’s :story has become ...
Acquisition to expand cardiovascular portfolio with complementary and differentiated calcium modification platform, ...